Evaxion Biotech A/S (EVAX) Q2 2024 Earnings Conference Call August 14, 2024 8:30 AM ET
Company Participants
Christian Kanstrup - Chief Executive Officer
Birgitte Rono - Chief Scientific Officer
Jesper Nissen - Chief Operating Officer and Chief Financial Officer
Mads Kronborg - Vice President, Investor Relations & Communication
Conference Call Participants
Li Chen - H.C. Wainwright
Thomas Flaten - Lake Street Capital Markets
Chong Liu - Ladenburg
Operator
Good day and thank you for standing by. Welcome to the Evaxion Biotech Business Update Conference call. [Operator Instructions] Please be advised, that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Christian Kanstrup, CEO. Please go ahead.
Christian Kanstrup
Good morning and good afternoon, everyone. And a very warm welcome to this Evaxion business update conference call on the back of our Q2 results. I'm Christian Kanstrup, CEO of Evaxion. With me today, I have Birgitte Rono, our CSO. I have Jesper Nyegaard Nissen, our COO and CFO. And I also have a new joiner with me today which is Mads Kronborg, VP Investor Relations and Communication. And I would actually like just to start out handing briefly over to Mads for a brief introduction to who you are. This is the first time you are attending the call here.
Mads Kronborg
Thank you, Christian. And thank you for the opportunity. And just for a brief introduction, I have some 15 years of experience in Corporate Communication and Investor Relations from the pharmaceutical and biotech industries, having early held positions like Head of Corporate Communication at Lundbeck and Head of IR and Communication at Zealand Pharma.
I'm glad to join Evaxion at this very interesting time for the company with a number of milestones lying ahead and I'm looking forward to help communicate our progress and facilitate the dialogue with you as investors, analysts and journalists. You will find my contact information on the Investors section of our website and are of course always welcome to get in touch.
Christian Kanstrup
I am pleased to have Mads on board so we can provide even better service and support to all of you. So great to have you on board, Mads.
Then let's jump to the next slide and look at the agenda for today. I'm going to do a brief introduction, then I'll hand over to Birgitte for an R&D business update, Jesper will be covering our financial results. I will conclude before we head into the Q&A part.